Raymond James analyst Jayson Bedford maintained a Buy rating on Abbott Labs (ABT - Research Report) today and set a price target of $109.00. The company's shares closed yesterday at $95.21.Bedford covers the Healthcare sector, focusing on stocks such as Intuitive Surgical, Abbott Labs, and AngioDynamics. According to TipRanks, Bedford has an average return of 9.5% and a 61.82% success rate on recommended stocks. In addition to Raymond James, Abbott Labs also received a Buy from Citigroup's Joanne Wuensch in a report issued yesterday. However, on October 12, Jefferies initiated coverage with a Hold rating on Abbott Labs (NYSE: ABT).
https://www.tipranks.com/news/blurbs/abbott-labs-abt-gets-a-buy-from-raymond-james?utm_source=advfn.com&utm_medium=referral